Our News

11.07

2019

Pharmathen is among the “Diamonds of the Greek Economy 2019”

Read more

11.06

2019

Pharmathen’ s distinction for its “Business Extroversion” for yet another year!

Another great distinction for our company!

Read more

17.05

2019

Our legal team is in the “Legal 500 2019 General Counsel Powerlist: Greece & Cyprus”.

We are proud of our legal team’s distinction to be among the “Legal 500 2019 General Counsel Powerlist: Greece & Cyprus” that were honored in a reception that took place in Athens on 16 May 2019.

Read more

30.04

2019

More investments in Northern Greece!

Pharmathen proceeded to new investments and acquired an additional 27-acres land in the Industrial Park of Sapes in order to expand its innovative business.

Read more

27.02

2019

Pharmathen’s 50 years Anniversary: A brilliant history; an even brighter future!

Pharmathen’s press event for its 50-years milestone

Read more

31.01

2019

Celebrating our 50-years Anniversary!

Coming together from all around the globe, we celebrated with our people 50 years of operation...

Read more

04.01

2019

Pharmathen ranked 1st among Greek companies investing in R&D based on the 2018 EU Industrial R&D Investment Scoreboard.

For yet another year, Pharmathen has been distinguished at the “2018 EU Industrial R&D Investment Scoreboard” and is ranked first among Greek companies based on R&D spending, by investing 33% of its turnover. With annual R&D spending of 49.9 million euros in the 2017-2018 period, Pharmathen ranked 396th on this year’s list of 1,000 companies in the EU with the highest R&D expenditure.

Read more

11.10

2018

CPhI Worldwide exhibition, Madrid

Our participation in CPhI 2018 Worldwide, the world's largest pharmaceutical exhibition, has been a great opportunity for our executives to meet and interact with hundreds of customers and partners coming from around the globe.

Read more

04.10

2018

CPHI 2018

For yet another year, Pharmathen participates at CPHI 2018 in Madrid @Stand No 9F31. We look forward to see you there!

Read more

01.12

2017

Pharmathen sells its commercial operations in Greece to focus exclusively on international markets

Amsterdam, 30/11/2017: Pharmathen, a BC Partners portfolio company, announces the sale of its Greek commercial operations as part of its long-term strategy to become a leader focused on the development of innovative and complex pharmaceuticals.

Read more